Nabi Biopharmaceuticals Overview
- Year Founded
-
1967
- Status
-
Acquired/Merged
- Employees
-
165
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
4
Nabi Biopharmaceuticals General Information
Description
Developer of vaccine products created for the treatment of nicotine addiction and prevention of smoking relapse. The company's innovative and proprietary clinical development programs are focused on powering the immune system to target serious medical conditions such as nicotine addiction and gram-positive bacterial infections.
Contact Information
Website
www.nabi.comCorporate Office
- 5800 Park of Commerce Boulevard
- Suite 322
- Boca Raton, FL 33487
- United States
Corporate Office
- 5800 Park of Commerce Boulevard
- Suite 322
- Boca Raton, FL 33487
- United States
Nabi Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nabi Biopharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nabi Biopharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nabi Biopharmaceuticals Investments & Acquisitions (4)
Nabi Biopharmaceuticals’s most recent deal was a Reverse Merger with Aviragen Therapeutics. The deal was made on 09-Nov-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aviragen Therapeutics | 09-Nov-2012 | Reverse Merger | Drug Discovery | ||
| Liminal Biosciences (Novel Plasma Fractionation Technology Rights) | 30-Aug-2006 | Corporate Asset Purchase | Buildings and Property | ||
| Aloprim | 30-Jun-2004 | Merger/Acquisition | Pharmaceuticals | ||
| Braintree Laboratories (PhosLo Product Line) | 08-Apr-2003 | Merger/Acquisition | Pharmaceuticals |
Nabi Biopharmaceuticals Exits (2)
Nabi Biopharmaceuticals’s most recent exit was on 09-Nov-2012 from Aviragen Therapeutics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Aviragen Therapeutics | 09-Nov-2012 | Completed |
|
||
| Aloprim | 30-Jun-2004 | Merger/Acquisition | Completed |
Nabi Biopharmaceuticals FAQs
-
When was Nabi Biopharmaceuticals founded?
Nabi Biopharmaceuticals was founded in 1967.
-
Where is Nabi Biopharmaceuticals headquartered?
Nabi Biopharmaceuticals is headquartered in Boca Raton, FL.
-
What is the size of Nabi Biopharmaceuticals?
Nabi Biopharmaceuticals has 165 total employees.
-
What industry is Nabi Biopharmaceuticals in?
Nabi Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is Nabi Biopharmaceuticals a private or public company?
Nabi Biopharmaceuticals is a Private company.
-
What is Nabi Biopharmaceuticals’s current revenue?
The current revenue for Nabi Biopharmaceuticals is .
-
How much funding has Nabi Biopharmaceuticals raised over time?
Nabi Biopharmaceuticals has raised $141M.
-
Who are Nabi Biopharmaceuticals’s investors?
Bear Stearns Companies, Lehman Brothers, Mangrove Partners, Merlin BioMed Group, and National Institute on Drug Abuse (NIDA) are 5 of 7 investors who have invested in Nabi Biopharmaceuticals.
-
When was Nabi Biopharmaceuticals acquired?
Nabi Biopharmaceuticals was acquired on 09-Nov-2012.
-
Who acquired Nabi Biopharmaceuticals?
Nabi Biopharmaceuticals was acquired by Aviragen Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
